168 related articles for article (PubMed ID: 7727141)
1. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor.
Holdright DR; Hunt BJ; Parratt R; Segal H; Clarke D; Taggart D; Bennett G; Collins P
Eur J Cardiothorac Surg; 1995; 9(1):18-21. PubMed ID: 7727141
[TBL] [Abstract][Full Text] [Related]
2. Release of von Willebrand factor by cardiopulmonary bypass, but not by cardioplegia in open heart surgery.
Valen G; Blombäck M; Sellei P; Lindblom D; Vaage J
Thromb Res; 1994 Jan; 73(1):21-9. PubMed ID: 8178310
[TBL] [Abstract][Full Text] [Related]
3. Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery.
Solomon C; Budde U; Schneppenheim S; Czaja E; Hagl C; Schoechl H; von Depka M; Rahe-Meyer N
Br J Anaesth; 2011 Apr; 106(4):494-500. PubMed ID: 21278152
[TBL] [Abstract][Full Text] [Related]
4. Release of creatine kinase, troponin-T, and tissue plasminogen activator in arterial and coronary venous blood during coronary artery bypass surgery.
Valen G; Owall A; Eriksson E; Kallner A; Risberg B; Vaage J
Scand J Clin Lab Invest; 1997 Feb; 57(1):85-93. PubMed ID: 9127461
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass.
Tsang GM; Allen S; Pagano D; Wong C; Graham TR; Bonser RS
Eur J Cardiothorac Surg; 1998 Apr; 13(4):385-91. PubMed ID: 9641336
[TBL] [Abstract][Full Text] [Related]
6. Changes in factor VIII proteins after cardiopulmonary bypass in man suggest endothelial damage.
Jones DK; Luddington R; Higenbottam TW; Scott J; Cavarocchi N; Reardon D; Calvin J; Wallwork J
Thromb Haemost; 1988 Oct; 60(2):199-204. PubMed ID: 2975406
[TBL] [Abstract][Full Text] [Related]
7. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
8. [Endothelial parameters in blood plasma of patients suffering from ischaemic heart disease and undergoing surgery with extracorporeal circulation].
Rość D; Ogorzeja W; Kotschy M; Missima M; Jurkowski P
Pol Arch Med Wewn; 2004 Nov; 112(5):1297-302. PubMed ID: 15773511
[TBL] [Abstract][Full Text] [Related]
9. Effects of transcutaneous aortic valve implantation on aortic valve disease-related hemostatic disorders involving von Willebrand factor.
Caspar T; Jesel L; Desprez D; Grunebaum L; Samet H; Trinh A; Petit-Eisenmann H; Kindo M; Ohlmann P; Morel O
Can J Cardiol; 2015 Jun; 31(6):738-43. PubMed ID: 25935884
[TBL] [Abstract][Full Text] [Related]
10. The role of von Willebrand factor in haemostasis and blood loss during and after cardiopulmonary bypass surgery.
Perrin EJ; Ray MJ; Hawson GA
Blood Coagul Fibrinolysis; 1995 Oct; 6(7):650-8. PubMed ID: 8562836
[TBL] [Abstract][Full Text] [Related]
11. Cardiac marker responses to coronary artery bypass graft surgery with cardiopulmonary bypass and aortic cross-clamping.
Takeda S; Nakanishi K; Ikezaki H; Kim C; Sakamoto A; Tanaka K; Ogawa R
J Cardiothorac Vasc Anesth; 2002 Aug; 16(4):421-5. PubMed ID: 12154418
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery.
Hernández-Romero D; Lahoz Á; Roldan V; Jover E; Romero-Aniorte AI; Martinez CM; Jara-Rubio R; Arribas JM; Garcia-Alberola A; Cánovas S; Valdés M; Marín F
Europace; 2016 Sep; 18(9):1328-34. PubMed ID: 26566941
[TBL] [Abstract][Full Text] [Related]
13. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
[TBL] [Abstract][Full Text] [Related]
14. Is hypothermia a benefit? Von Willebrand factor in pediatric cardiopulmonary bypass.
Bec L; Karolczak MA; Motylewicz B; Rogala E
J Cardiovasc Surg (Torino); 2006 Apr; 47(2):211-5. PubMed ID: 16572096
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline preloading reduces endothelial injury and permeability in cardiopulmonary bypass.
Tsang GM; Allen S; Pagano D; Wong C; Graham TR; Bonser RS
ASAIO J; 1996; 42(5):M429-34. PubMed ID: 9063959
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
Valen G; Eriksson E; Risberg B; Vaage J
Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor in aortic or mitral valve stenosis and bleeding after heart valve surgery.
Mazur P; Natorska J; Ząbczyk M; Krzych Ł; Litwinowicz R; Kędziora A; Kapelak B; Undas A
Thromb Res; 2021 Feb; 198():190-195. PubMed ID: 33360153
[TBL] [Abstract][Full Text] [Related]
18. Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery.
Lo B; Nierich AP; Kalkman CJ; Fijnheer R
Thromb Haemost; 2007 Jan; 97(1):21-6. PubMed ID: 17200766
[TBL] [Abstract][Full Text] [Related]
19. The influence of venous occlusion on the status of protein S.
Monte G; Lindo VS; Radicchia S; Melissari E; Kakkar VV
Blood Coagul Fibrinolysis; 1991 Oct; 2(5):589-93. PubMed ID: 1838283
[TBL] [Abstract][Full Text] [Related]
20. Short-term prognostic value of perioperative coronary sinus-derived-serum cardiac troponin-I, creatine kinase-MB, lactate, pyruvate, and lactate-pyruvate ratio in adult patients undergoing open heart surgery.
Chowdhury UK; Sheil A; Kapoor PM; Narang R; Gharde P; Malik V; Kalaivani M; Chaudhury A
Ann Card Anaesth; 2016; 19(3):439-53. PubMed ID: 27397448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
